Bích-Mây Nguyễn :verified: on Nostr: "The maker of a much-debated drug for Lou Gehrig’s disease said Friday its therapy ...

"The maker of a much-debated drug for Lou Gehrig’s disease said Friday its therapy failed to help patients in a large follow-up study, but stopped short of committing to follow through on a prior pledge to pull the drug from the U.S. market...The latest company study showed that the drug did not slow the disease compared with a dummy treatment. The drug also failed to show improvement on any secondary measures, such as muscle strength."

https://apnews.com/article/als-drug-fda-relyvrio-study-patients-7340ef880306fbbadad720b8154b3605

#PrescriptionDrugs #FDA #ALS